A Phase Ii Study Of Glembatumumab Vedotin (Gv), An Antibody-Drug Conjugate (Adc) Targeting Gpnmb, In Advanced MelanomaPatrick Alexander Ott,Anna C. Pavlick,Douglas Buckner Johnson,Lowell L. Hart,Jeffrey R. Infante,Jason John Luke,Jose Lutzky, Neal Evan Rothschild,Lynn E. Spitler,Charles Lance Cowey,Aaron Alizadeh,April K. Salama, Xiaoyan Yin,Rebecca G. Bagley,Ying Wang,Omid HamidJOURNAL OF CLINICAL ONCOLOGY(2017)引用 9|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要